Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Dividends Paid - Common (2022 - 2025)

Historic Dividends Paid - Common for Iradimed (IRMD) over the last 4 years, with Q3 2025 value amounting to $2.2 million.

  • Iradimed's Dividends Paid - Common rose 1379.14% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year decrease of 2877.93%. This contributed to the annual value of $13.7 million for FY2024, which is 343.74% up from last year.
  • Latest data reveals that Iradimed reported Dividends Paid - Common of $2.2 million as of Q3 2025, which was up 1379.14% from $2.2 million recorded in Q2 2025.
  • Iradimed's 5-year Dividends Paid - Common high stood at $13.2 million for Q1 2023, and its period low was $1.9 million during Q2 2024.
  • In the last 4 years, Iradimed's Dividends Paid - Common had a median value of $2.2 million in 2025 and averaged $5.1 million.
  • The largest annual percentage gain for Iradimed's Dividends Paid - Common in the last 5 years was 1379.14% (2025), contrasted with its biggest fall of 7289.97% (2025).
  • Iradimed's Dividends Paid - Common (Quarter) stood at $12.6 million in 2022, then increased by 5.29% to $13.2 million in 2023, then plummeted by 85.62% to $1.9 million in 2024, then grew by 13.74% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.2 million for Q2 2025, and $2.2 million during Q1 2025.